Conditionality of COVID-19 vaccine acceptance in European countries

  1. Leonardo W. Heyerdahl
  2. Muriel Vray
  3. Benedetta Lana
  4. Nastassia Tvardik
  5. Nina Gobat
  6. Marta Wanat
  7. Sarah Tonkin-Crine
  8. Sibyl Anthierens
  9. Herman Goossens
  10. Tamara Giles-Vernick

Reviewed by

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1016/j.vaccine.2022.01.054
  2. ScreenIT

    SciScore for 10.1101/2021.06.24.21259453: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    EthicsIRB: The University of Antwerp ethics committee provide ethical approval (20/13/150).
    Consent: All participants furnished informed consent before participating in the survey.
    Sex as a biological variablenot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    Data were analyzed using STATA Software Version 15.1 (Stata Corporation, College Station, Texas, USA).
    STATA
    suggested: (Stata, RRID:SCR_012763)
    NVivo software (Windows Release 1, QSR International) supported the qualitative data analysis.
    NVivo
    suggested: (NVivo, RRID:SCR_014802)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).

    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    There are two limitations of this preliminary analysis. First, survey panels select representative samples among age and gender groups, regions, and working status, but they draw heavily from those with internet access and of higher educational achievements. Hence, they are not fully representative. In addition, the survey was conducted in December 2020. Since then, the European Medicines Agency has approved other vaccines, and vaccine rollout for specific age groups has begun, although at different rates and with access to different vaccines.

    Results from TrialIdentifier: No clinical trial numbers were referenced.

    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.

    Results from JetFighter: We did not find any issues relating to colormaps.

    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  3. Version published to 10.1101/2021.06.24.21259453 on medRxiv